Kymera Therapeutics KYMR
$ 40.17
2.62%
Quarterly report 2024-Q3
added 10-31-2024
Kymera Therapeutics EV/EBITDA Ratio 2011-2024 | KYMR
Annual EV/EBITDA Ratio Kymera Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-21.5 | -28.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-21.5 | -28.6 | -25.1 |